Skip to Main Content

Paper Details

Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.
Pediatr Nephrol
21
2016
AMR, Bortezomib, C4d, HLA, HLA DSAs, acute cellular rejection, anti-CD25 monoclonal antibody, antibody-mediated rejection, antithymocyte globulin, bortezomib, calcineurin, human, human leukocyte antigen, patient, patients
Author NameAffiliation
Qiuheng ZhangDavid Geffen School of Medicine, University of California Los Angeles
Qiuheng ZhangDavid Geffen School of Medicine, University of California Los Angeles
Elaine F ReedDavid Geffen School of Medicine, University of California Los Angeles
Elaine F ReedDavid Geffen School of Medicine, University of California Los Angeles
  • 1 - 4

Datasets

Release 1.2